Abstract
A competitive binding radioassay was developed to measure 5‐fluoro‐2′‐deoxyuridine (FUDR) as well as 5‐fluoro‐2′‐deoxyuridine monophosphate (FdUMP). FdUMP has been measured by a competitive binding radioassay with thymidylate synthase as the binding enzyme (TS assay). FUDR was enigmatically converted to FdUMP by thymidine kinase, and then the converted FdUMP was measured by the competitive binding assay to determine the concentration of FUDR in plasma and tumor tissue. As little as 100 pg/ml of FUDR or 50 pg/ml of FdUMP can be detected quantitatively by this method. When TS assay and high‐performance liquid chromatography were compared for the measurement of FUDR and FdUMP levels in plasma and tumor tissue of Ehrlich carcinoma (EQ‐bearing mice following administration of FUDR, a close agreement was observed for FUDR levels, though low FdUMP levels were detectable only by the TS assay method. The examination of intracellular metabolism of FUDR in EC cells by this method showed that metabolic conversion of FUDR into FdUMP or 5‐fluorouracil is rapid. Thus, we have established a highly sensitive method for measuring not only FdUMP but also FUDR with TS assay. This should be very useful for experimental and clinical studies on fluoropyrimidines.
Keywords: FUDR, FdUMP, Thymidylate synthase, Thymidine kinase, Binding radioassay
Full Text
The Full Text of this article is available as a PDF (331.9 KB).
REFERENCES
- 1. ) Tokyo Cancer Chemotherapy Cooperative . Group study of fluorinated pyrimidines . In “ Fluoropyrimidines in Cancer Therapy ”, ed. Kimura K. , Fujii S. , Ogawa M. , Bodey G. P. and Alberto P. , pp. 242 – 250 ( 1983. ). Elsevier Science Publishers B.V. , Amsterdam . [Google Scholar]
- 2. ) Bosch , L. , Harbers , H. and Heidelberger , C.Studies on fluorinated pyrimidine. V. Effect on nucleic acid metabolism in vitro . Cancer Res. , 18 , 335 – 343 ( 1958. ). [PubMed] [Google Scholar]
- 3. ) Hartman , K. Y. and Heidelberger , C.Studies on fluorinated pyrimidines. XIII. Inhibition of thymidylate synthetase . J. Biol. Chem. , 236 , 3006 – 3018 ( 1961. ). [PubMed] [Google Scholar]
- 4. ) Langerback , R. J. , Danenberg , P. V. and Heidelberger , C.Thymidylate synthetase: mechanism of inhibition by 5‐fluoro‐2′‐deoxy‐uridylate . Biochem. Biophys. Res. Commun. , 48 , 1565 – 1571 ( 1972. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Wilkinson , D. S. , Tlsty , T. D. and Hanas , R. J.The inhibition of ribosomal RNA synthesis and maturation in Novikoff hepatoma cell by 5‐fluorouridine . Cancer Res. , 35 , 3014 – 3020 ( 1975. ). [PubMed] [Google Scholar]
- 6. ) Kessel , D. and Wodiusky , I.Thymidine kinase as a determinant of the response to 5‐fluoro‐2′‐deoxyuridine in transplantable murine leukemias . Mol Pharmacol. , 6 , 251 – 254 ( 1969. ). [PubMed] [Google Scholar]
- 7. ) Bresnick , E. and Thompson , U. B.Properties of deoxythymidine kinase partially purified from animal tumor . J. Biol. Chem. , 240 , 3967 – 3973 ( 1965. ). [PubMed] [Google Scholar]
- 8. ) Woodman , P. W. , Sarrif , A. M. and Heidelberger , C.Specificity of pyrimidine nucleoside phosphorylases and phosphorolysis of 5‐fluoro‐2′‐deoxyuridine . Cancer Res. , 40 , 507 – 511 ( 1980. ). [PubMed] [Google Scholar]
- 9. ) Chu , M. Y. , Naguib , F. N. M. , Iltasch , M. H. , el Kouni , M. H. , Chu , S. H. , Cha , S. and Calabresi , P.Potentiation of 5‐fluoro‐2′‐deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine . Cancer Res. , 44 , 1852 – 1856 ( 1984. ). [PubMed] [Google Scholar]
- 10. ) Murinson , D. S. , Anderson , T. , Schwartz , H. S. , Myers , C. E. and Chabner , B. A.Competitive binding radioassay for 5‐fluorodeoxyuridine 5′‐monophosphate in tissue . Cancer Res. , 39 , 2471 – 2475 ( 1979. ). [PubMed] [Google Scholar]
- 11. ) Benvenuto , J. A. , Lu , K. and Loo , T. L.High‐pressure liquid chromatographic analysis of ftorafur and its metabolites in biological fluids . J. Chmmatogr. , 134 , 219 – 222 ( 1977. ). [DOI] [PubMed] [Google Scholar]
- 12. ) McAllister , R. M. , Grunmeier , P. W. , Corieli , L. L. , and Blakemore , W. S.A quantitative technique for the measurement of in vitro cytotoxicity of 5‐fluoro‐2′‐deoxy‐uridine, nitrogen mustard (NH2), and other antitumor agents . Cancer , 12 , 938 – 943 ( 1959. ). [Google Scholar]
- 13. ) Kanazawa , F. , Hoshi , A. , Kuretani , K. , Saneyoshi , M. and Kawaguchi , T.Antitumor activity of 3′,5′‐diesters of 5‐fluoro‐2′‐deoxyuridine against murine leukemia L1210 cells . Cancer Chemother. Pharmacol. , 6 , 19 – 23 ( 1981. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Cheng , Y‐C. and Prusoff , W. H.Mouse ascites sarcoma 180 deoxythymidine kinase. General properties and inhibition studies . Biochemistry , 13 , 1179 – 1185 ( 1974. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Dunlap , R. B. , Harding , N. G. L. and Heuneckens , F. M.Thymidylate synthetase from amethopterin‐resistant Lactobacillus casei . Biochemistry , 10 , 88 – 97 ( 1971. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Diasio , R. B. and Bowen , D.Rapid simultaneous analysis of fluoropyrimidine metabolite pools by a high performance liquid chromatographic‐isotopic method . Proc. Am. Assoc. Cancer Res. , 19 , 132 ( 1978. ). [Google Scholar]
- 17. ) Myers , C. E. , Young , R. C. , Johns , D. G. and Chabner , B. A.Assay of 5′‐fluorodeoxy uridine 5′‐monophosphate and deoxyuridine 5′‐monophosphate pools following 5‐fluorouracil . Cancer Res. , 34 , 2682 – 2688 ( 1974. ). [PubMed] [Google Scholar]
- 18. ) Birnie , G. D. , Kroeger , H. and Heidelberger , C.Studies of fluorinated pyrimidines. XIII. The degradation of 5‐fluoro‐2′‐deoxyuridine and related compounds by nucleoside phosphorylase . Biochemistry , 2 , 566 – 572 ( 1962. ). [DOI] [PubMed] [Google Scholar]